MDxHealth SA Ordinary Shares (MDXH) is a publicly traded Healthcare sector company. As of May 21, 2026, MDXH trades at $0.87 with a market cap of $43.61M and a P/E ratio of 0.00. MDXH moved +2.42% today. Year to date, MDXH is -73.41%; over the trailing twelve months it is -59.26%. Its 52-week range spans $0.68 to $5.33. Analyst consensus is strong buy with an average price target of $3.09. Rallies surfaces MDXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MDxHealth Sees Q1 2026 Revenue Jump and Refocus on Diagnostic Platforms: MDxHealth SA posted a sharp revenue surge in Q1 2026 and narrowed its operating deficit through disciplined cost controls. Management outlined a strategic refocus on expanding its molecular diagnostic offerings and forging partnerships to drive broader commercial adoption of its ConfirmMDx test.
| Metric | Value |
|---|---|
| Price | $0.87 |
| Market Cap | $43.61M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.33 |
| 52-Week Low | $0.68 |
| Volume | 4.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover MDXH: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.09.